Checkpoint Inhibitor

Checkpoint inhibitors are a type of immunotherapy being tested in pancreatic cancer to help the immune system fight tumors. While these treatments have been successful in other cancers, researchers are exploring ways to make them work for Canadians living with pancreatic cancer. This collection covers the latest research, clinical trials, and emerging combinations—like pairing checkpoint inhibitors with chemotherapy or oncolytic viruses—to improve treatment options.